|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/91 | |
| C07D 403/04 | |||
| C07D 403/02 | |||
| A61K 31/517 | |||
| A61K 31/519 | |||
| A61P 9/00 |
| (11) | Number of the document | 2382194 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10704977.7 |
| Date of filing the European patent application | 2010-01-08 | |
| (97) | Date of publication of the European application | 2011-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2010/000159 |
| Date | 2010-01-08 |
| (87) | Number | WO 2010/079431 |
| Date | 2010-07-15 |
| (30) | Number | Date | Country code |
| 143276 P | 2009-01-08 | US |
| (72) |
HANSEN, C., Henrik, CA
|
| (73) |
RESVERLOGIX CORP.,
202, 279 Midpark Way S.E., Calgary, Alberta T2X 1M2,
CA
|
| (54) | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE |
| COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE |